{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T07:24:46Z","timestamp":1779348286611,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,9,19]],"date-time":"2010-09-19T00:00:00Z","timestamp":1284854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Biol Toxicol"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s10565-010-9175-1","type":"journal-article","created":{"date-parts":[[2010,9,18]],"date-time":"2010-09-18T17:10:46Z","timestamp":1284829846000},"page":"123-131","source":"Crossref","is-referenced-by-count":4,"title":["Semi-high throughput method of measuring proteasome inhibition in vitro and in cultured cells"],"prefix":"10.1007","volume":"27","author":[{"given":"Khandan","family":"Keyomarsi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekem T.","family":"Efuet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuyen N.","family":"Bui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,19]]},"reference":[{"key":"9175_CR1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1367-5931(02)00343-5","volume":"6","author":"J Adams","year":"2002","unstructured":"Adams J. Preclinical and clinical evaluation of proteasome inhibitor PS-341 for the treatment of cancer. Curr Opin Chem Biol. 2002;6:493\u2013500.","journal-title":"Curr Opin Chem Biol."},{"key":"9175_CR2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.0022-202X.2005.23809.x","volume":"125","author":"JL Arbiser","year":"2005","unstructured":"Arbiser JL et al. Naturally occurring proteasome inhibitors from mate tea (Ilex paraguayensis) serve as models for topical proteasome inhibitors. J Invest Dermatol. 2005;125:207\u201312.","journal-title":"J Invest Dermatol."},{"key":"9175_CR3","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/jnci\/djj309","volume":"98","author":"C Brignole","year":"2006","unstructured":"Brignole C et al. Effect of bortezomib on human neuroblastoma cell growth, apoptosis, and angiogenesis. J Natl Cancer Inst. 2006;98:1142\u201357.","journal-title":"J Natl Cancer Inst."},{"key":"9175_CR4","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1158\/1535-7163.MCT-05-0437","volume":"5","author":"SE Canfield","year":"2006","unstructured":"Canfield SE, Zhu K, Williams SA, McConkey DJ. Bortezomib inhibits docetaxel-induced apoptosis via a p21-dependent mechanism in human prostate cancer cells. Mol Cancer Ther. 2006;5:2043\u201350.","journal-title":"Mol Cancer Ther."},{"key":"9175_CR5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0003-9861(02)00493-9","volume":"408","author":"C Cardozo","year":"2002","unstructured":"Cardozo C, Michaud C. Proteasome-mediated degradation of tau proteins occurs independently of the chymotrypsin-like activity by a nonprocessive pathway. Arch Biochem Biophys. 2002;408:103\u201310.","journal-title":"Arch Biochem Biophys."},{"key":"9175_CR6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev.pharmtox.45.120403.100037","volume":"45","author":"D Chauhan","year":"2005","unstructured":"Chauhan D, Hideshima T, Anderson KC. Proteasome inhibition in multiple myeloma: therapeutic implication. Annu Rev Pharmacol Toxicol. 2005;45:465\u201376.","journal-title":"Annu Rev Pharmacol Toxicol."},{"key":"9175_CR7","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/75406","volume":"18","author":"NP Dantuma","year":"2000","unstructured":"Dantuma NP, Lindsten K, Glas R, Jellne M, Masucci MG. Short-lived green fluorescent proteins for quantifying ubiquitin\/proteasome-dependent proteolysis in living cells. Nat Biotechnol. 2000;18:538\u201343.","journal-title":"Nat Biotechnol."},{"key":"9175_CR8","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1158\/0008-5472.CAN-05-3416","volume":"66","author":"ET Efuet","year":"2006","unstructured":"Efuet ET, Keyomarsi K. Farnesyl and geranylgeranyl transferase inhibitors induce G1 arrest by targeting the proteasome. Cancer Res. 2006;66:1040\u201351.","journal-title":"Cancer Res."},{"key":"9175_CR9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/anie.200390115","volume":"42","author":"RH Feling","year":"2003","unstructured":"Feling RH et al. Salinosporamide A: a highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus salinospora. Angew Chem Int Ed Engl. 2003;42:355\u20137.","journal-title":"Angew Chem Int Ed Engl."},{"key":"9175_CR10","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1021\/jm049660v","volume":"47","author":"P Furet","year":"2004","unstructured":"Furet P et al. Entry into a new class of potent proteasome inhibitors having high antiproliferative activity by structure-based design. J Med Chem. 2004;47:4810\u20133.","journal-title":"J Med Chem."},{"key":"9175_CR11","first-page":"1717","volume":"20","author":"J Golab","year":"2000","unstructured":"Golab J et al. Synergistic antitumor effects of a selective proteasome inhibitor and TNF in mice. Anticancer Res. 2000;20:1717\u201321.","journal-title":"Anticancer Res."},{"key":"9175_CR12","doi-asserted-by":"crossref","first-page":"22260","DOI":"10.1074\/jbc.M112360200","volume":"277","author":"AF Kisselev","year":"2002","unstructured":"Kisselev AF, Kaganovich D, Goldberg AL. Binding of hydrophobic peptides to several non-catalytic sites promotes peptide hydrolysis by all active Sites of the 20S proteasome: evidence for peptide-induced channel opening of the alpha-rings. JBC. 2002;277:22260\u201370.","journal-title":"JBC"},{"key":"9175_CR13","doi-asserted-by":"crossref","first-page":"8582","DOI":"10.1074\/jbc.M509043200","volume":"281","author":"AF Kisselev","year":"2006","unstructured":"Kisselev AF, Callard A, Goldberg AL. Importance of the different proteolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate. J Biol Chem. 2006;281:8582\u201390.","journal-title":"J Biol Chem."},{"key":"9175_CR14","doi-asserted-by":"crossref","first-page":"967","DOI":"10.7164\/antibiotics.53.967","volume":"53","author":"Y Koguchi","year":"2000","unstructured":"Koguchi Y et al. TMC-89A and B, new proteasome inhibitors from streptomyces sp. TC 1087. J Antibiot (Tokyo). 2000;53:967\u201372.","journal-title":"J Antibiot (Tokyo)."},{"issue":"8","key":"9175_CR15","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nbt851","volume":"21","author":"K Lindsten","year":"2003","unstructured":"Lindsten K et al. A transgenic mouse model of the ubiquitin\/proteasome system. Nat Biotechnol. 2003;21(8):897\u2013902.","journal-title":"Nat Biotechnol"},{"key":"9175_CR16","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/nm894","volume":"9","author":"GD Luker","year":"2003","unstructured":"Luker GD, Pica CM, Song J, Luker KE, Piwnica-Worms D. Imaging 26S proteasome activity and inhibition in living mice. Nat Med. 2003;9:969\u201373.","journal-title":"Nat Med"},{"key":"9175_CR17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ab.2009.01.016","volume":"387","author":"RA Moravec","year":"2009","unstructured":"Moravec RA et al. Cell-based bioluminescent assays for all three proteasome activities in a homogeneous format. Anal Biochem. 2009;387:294\u2013304.","journal-title":"Anal Biochem"},{"issue":"1","key":"9175_CR18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.tcb.2004.11.003","volume":"15","author":"M Rechsteiner","year":"2005","unstructured":"Rechsteiner M, Hill CP. Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors. Trends Cell Biol. 2005;15(1):27\u201333.","journal-title":"Trends Cell Biol"},{"key":"9175_CR19","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1056\/NEJMoa030288","volume":"348","author":"PG Richardson","year":"2003","unstructured":"Richardson PG et al. A phase 2 study of bortezomib in relapsed, refractory myeloma. N Engl J Med. 2003;348:2609\u201317.","journal-title":"N Engl J Med"},{"key":"9175_CR20","doi-asserted-by":"crossref","first-page":"29860","DOI":"10.1016\/S0021-9258(18)43960-9","volume":"269","author":"A Vinitsky","year":"1994","unstructured":"Vinitsky A, Cardozo C, Sepp-Lorenzino L, Michaud C, Orlowski M. Inhibition of the proteolytic activity of the multicatalytic proteinase complex (proteasome) by substrate-related peptidyl aldehydes. J Biol Chem. 1994;269:29860\u20136.","journal-title":"J Biol Chem"},{"key":"9175_CR21","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1158\/0008-5472.CAN-05-3692","volume":"66","author":"N Zaarur","year":"2006","unstructured":"Zaarur N, Gabai VL, Porco Jr JA, Calderwood S, Sherman MY. Targeting heat shock response to sensitize cancer cells to proteasome and Hsp90 inhibitors. Cancer Res. 2006;66:1783\u201391.","journal-title":"Cancer Res"}],"container-title":["Cell Biology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-010-9175-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10565-010-9175-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-010-9175-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T05:20:46Z","timestamp":1636521646000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10565-010-9175-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,19]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["9175"],"URL":"https:\/\/doi.org\/10.1007\/s10565-010-9175-1","relation":{},"ISSN":["0742-2091","1573-6822"],"issn-type":[{"value":"0742-2091","type":"print"},{"value":"1573-6822","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,19]]}}}